The most common patient complaints are minor: soreness at injection site, a transient headache, or mild diarrhea
At that point, recovery is unreliable, and the batch often has to be discarded
Every fat-metabolism, NAD+, SIRT1 and lean-mass effect described above is preclinical (rodent or cell) only and should be read as a hypothesis, not an established human benefit
This research compound has garnered significant scientific interest for its potential involvement in angiogenesis, collagen synthesis, and inflammatory response modulation at the molecular level
However, there is a meaningful distinction between individual informed decision-making for refractory cases and blanket availability through compounding pharmacies and online telehealth services, which would introduce the compound to a much broader population - including patients with mild or self-limiting conditions - for whom the risk-reward calculus is far less favorable